2-(3-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-9-methyl-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4788961

PubChem CID: 162669020

Max Phase: Preclinical

Molecular Formula: C24H27N7O2

Molecular Weight: 445.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(Nc2ncc3c(n2)-c2ccc(C)cc2NC(=O)N3)ccc1N1CCN(C)CC1

Standard InChI:  InChI=1S/C24H27N7O2/c1-15-4-6-17-18(12-15)27-24(32)28-19-14-25-23(29-22(17)19)26-16-5-7-20(21(13-16)33-3)31-10-8-30(2)9-11-31/h4-7,12-14H,8-11H2,1-3H3,(H,25,26,29)(H2,27,28,32)

Standard InChI Key:  BUCZNRQLDOKWFS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   26.1487  -13.9500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.1476  -14.7695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8556  -15.1785    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.8538  -13.5411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5655  -14.7705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5624  -13.9464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2075  -13.4244    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.0153  -13.5996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3767  -14.3431    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.0245  -15.0934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2194  -15.2812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9809  -16.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5465  -16.6734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3538  -16.4810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5885  -15.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5201  -12.9570    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.4395  -15.1776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.4389  -15.9948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7307  -16.4012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7297  -17.2177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4377  -17.6276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1480  -17.2152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1455  -16.4001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4381  -18.4448    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7280  -18.8506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7265  -19.6642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4326  -20.0762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.1419  -19.6685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1450  -18.8487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4299  -20.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9155  -17.0746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0215  -17.6254    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.3143  -17.2159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
 14 31  1  0
 20 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4788961

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.53Molecular Weight (Monoisotopic): 445.2226AlogP: 3.91#Rotatable Bonds: 4
Polar Surface Area: 94.65Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.73CX Basic pKa: 7.54CX LogP: 3.68CX LogD: 3.31
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.27

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source